Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Review
. 2018 Oct;8(5):610-620.
doi: 10.21037/cdt.2018.05.06.

Impact of genetic polymorphisms on platelet function and response to anti platelet drugs

Teresa Strisciuglio  1 , Danilo Franco  1 , Giuseppe Di Gioia  1 , Chiara De Biase  1 , Carmine Morisco  1 , Bruno Trimarco  1 , Emanuele Barbato  1
Affiliations
Review

Impact of genetic polymorphisms on platelet function and response to anti platelet drugs

Teresa Strisciuglio et al. Cardiovasc Diagn Ther. 2018 Oct.

Abstract

Cardiovascular genomic consists in the identification of polymorphic genes responsible for the susceptibility to cardiovascular disease including coronary artery disease (CAD). Genes involved in platelet activation and aggregation play a key role in the predisposition to CAD. A considerable inter-variability of platelet response to agonists and to drugs exists and in particular the hyper-reactivity phenotype seems to be heritable. Besides glycoproteins and receptors expressed on platelets surface whose mutations significantly impact on platelet function, moreover researchers in the last decades have paid great attention to the genes involved in the response to anti-platelet drugs, considering their pivotal role in the treatment and outcomes of CAD patients especially those undergoing PCI. With the outbreak of advanced techniques developed to analyse human genetic footprints, researchers nowadays have shifted from genetic linkage analysis and a candidate gene approach toward genome-wide association (GWAS) studies and the analysis of miRNA-mRNA expression profiles.

Keywords: Genetic polymorphism; high on treatment platelet reactivity; platelets function.

PubMed Disclaimer

Conflict of interest statement

Conflicts of Interest: The authors have no conflicts of interest to declare.

References

    1. Wung SF, Hickey KT, Taylor JY, et al. Cardiovascular genomics. J Nurs Scholarsh 2013;45:60-8. 10.1111/jnu.12002 - DOI - PMC - PubMed
    1. Gigante B, Bellis A, Visconti R, et al. Retrospective analysis of coagulation factor II receptor (F2R) sequence variation and coronary heart disease in hypertensive patients. Arterioscler Thromb Vasc Biol 2007;27:1213-9. 10.1161/ATVBAHA.107.140541 - DOI - PubMed
    1. Andresdottir MB, Sigurdsson G, Sigvaldason H, et al. Fifteen percent of myocardial infarctions and coronary revascularizations explained by family history unrelated to conventional risk factors. The Reykjavik Cohort Study. Eur Heart J 2002;23:1655-63. 10.1053/euhj.2002.3235 - DOI - PubMed
    1. Vaidya D, Yanek LR, Moy TF, et al. Incidence of coronary artery disease in siblings of patients with premature coronary artery disease: 10 years of follow-up. Am J Cardiol 2007;100:1410-5. 10.1016/j.amjcard.2007.06.031 - DOI - PMC - PubMed
    1. Trip MD, Cats VM, van Capelle FJ, et al. Platelet hyperreactivity and prognosis in survivors of myocardial infarction. N Engl J Med 1990;322:1549-54. 10.1056/NEJM199005313222201 - DOI - PubMed